SYDNEY, Australia — Apomorphine may represent a novel therapeutic agent to reduce the burden of cognitive impairment in patients with Parkinson's disease (PD). Preliminary findings from a study from ...

Please provide your email address to receive an email when new articles are posted on . Apomorphine sublingual film resulted in greater motor improvement and an increase in responders at earlier time ...

Please provide your email address to receive an email when new articles are posted on . Apomorphine may provide relief for patients with Parkinson’s disease during periods of immobility related to ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced Parkinson's disease, Supernus Pharmaceuticals announced on Tuesday. The ...

Apomorphine, a 150-year-old drug for Parkinson’s disease is found to lower ‘off’ time for people at an advanced stage of the disease. Apomorphine has been in use for many years, but its significance ...

Apomorphine sublingual film (Kynmobi, Sunovion Pharmaceuticals) was efficacious and generally safe and well tolerated for the on-demand treatment of OFF episodes in Parkinson's disease, long-term ...

The difference in score change for movement disorder from baseline to 30 minutes post-dose between the apomorphine and placebo group was 7.6 (P=0.0002). Sunovion announced that apomorphine sublingual ...

Patients should receive training on the proper use of the delivery device prior to starting treatment. The Food and Drug Administration (FDA) has approved Onapgo™ (apomorphine hydrochloride [HCl]) for ...

Review the side-effects of Apomorphine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

- The first and only sublingual therapy for the on-demand treatment of OFF episodes in patients with Parkinson’s disease is now available in the United States - MARLBOROUGH, Mass.--(BUSINESS ...

Lal et al 1 showed in a placebo-controlled double-blind study on healthy volunteers that apomorphine injected subcutaneously (s.c) was able to induce erection. However, side effects limited its ...

The clinical profile for apomorphine sublingual (SL), a new centrally active agent for the management of the erectile dysfunction (ED) patient, is described in this article. Apomorphine SL is shown to ...